Company: HURA
Filing Date: 2025-11-04
Form Type: 8-K
Source: 0001193125-25-263523
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-04
Form: 8-K
Item: Item 1.01
Chunk 1
---
 notice to the other party. The Company currently intends to use all proceeds raised in connection with the sale of shares of Common Stock for working capital and general corporate purposes.

The Offering Agreement contains representations, warranties and covenants that are customary for transactions of this type. In addition, the Company has agreed to provide indemnification and contribution to Wainwright against certain liabilities.

The foregoing description of the Offering Agreement is qualified in its entirety by reference to the full text of the Offering Agreement, a copy of which is included as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.